Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

JAM-A Inhibitors

Common JAM-A Inhibitors include, but are not limited to Curcumin CAS 458-37-7, (-)-Epigallocatechin Gallate CAS 989-51-5, Quercetin CAS 117-39-5, Resveratrol CAS 501-36-0 and D,L-Sulforaphane CAS 4478-93-7.

Junctional Adhesion Molecule-A (JAM-A) is an integral membrane protein found at tight junctions in epithelial and endothelial cells. It plays a significant role in cell-cell adhesion, regulating cell permeability, and maintaining cell polarity. Additionally, JAM-A is involved in various cellular processes, including cell migration, proliferation, and differentiation. Its role is especially pronounced in inflammatory responses, where it mediates leukocyte transendothelial migration-a critical step in inflammation.

JAM-A inhibitors are molecules designed to modulate the function of JAM-A, primarily targeting its role in cell adhesion and migration. By inhibiting JAM-A, these compounds can impact the integrity of tight junctions, affecting barrier function in epithelial and endothelial tissues. Furthermore, given JAM-A's involvement in inflammatory processes, its inhibitors can also modulate the movement of immune cells across endothelial barriers. The study of JAM-A inhibitors provides deeper insights into the protein's function in health and disease. Through the design and evaluation of these inhibitors, researchers can dissect the molecular mechanisms underlying cell-cell adhesion, tight junction formation, and the regulation of inflammatory responses.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin, a polyphenol found in turmeric, may suppress JAM-A expression by modulating inflammatory pathways and reducing oxidative stress.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG, a catechin from green tea, might down-regulate JAM-A by inhibiting inflammatory cytokines and pathways involved in cell adhesion.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$108.00
$245.00
$918.00
$49.00
33
(2)

Quercetin, a flavonoid, can potentially reduce JAM-A expression by attenuating inflammation and oxidative stress in cells.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol can potentially inhibit JAM-A by modulating signaling pathways associated with inflammation and endothelial function.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$150.00
$286.00
$479.00
$1299.00
$8299.00
$915.00
22
(1)

Sulforaphane may suppress JAM-A expression by reducing oxidative stress and modulating inflammatory signaling pathways.

N-Acetyl-L-cysteine

616-91-1sc-202232
sc-202232A
sc-202232C
sc-202232B
5 g
25 g
1 kg
100 g
$33.00
$73.00
$265.00
$112.00
34
(1)

NAC might down-regulate JAM-A by acting as an antioxidant and modulating oxidative stress-related pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125, a JNK inhibitor, may reduce JAM-A expression by inhibiting JNK-mediated signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002, a PI3K inhibitor, might inhibit JAM-A expression by affecting PI3K/Akt signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059, an ERK inhibitor, could potentially reduce JAM-A by affecting the MAPK/ERK signaling pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580, a p38 MAPK inhibitor, might down-regulate JAM-A by affecting the p38 MAPK pathway.